InvestorsHub Logo
Followers 0
Posts 775
Boards Moderated 0
Alias Born 11/14/2013

Re: JohnnyShoe post# 9993

Thursday, 10/09/2014 9:44:04 AM

Thursday, October 09, 2014 9:44:04 AM

Post# of 128598
Bedrocan is not wrong that they have more Revenue than Tweed last Q.

(Bedrocan)Revenues of medicinal cannabis to authorized patients in Canada were $0.37 million for the second quarter ended June 30, 2014 ("Q2 2014"), and $0.46 million for the six-month period ended June 30, 2014.
Read more at www.stockhouse.com/news/press-releases/2014/08/28/financial-and-operational-highlights-from-bedrocan-s-second-quarter-results#lX63tKxOLamSKebo.99



(Tweed)The Company reported initial sales(revenue) of $188,736, coming from the last two months of the quarter.
Read more at www.stockhouse.com/news/press-releases/2014/08/27/tweed-announces-fiscal-q2-results-and-provides-update#ToZUxS3Kh7bgal3r.99



But who cares? Tweed made 200k on their own supply and it was two months of limited sales/stock. I really would not be shocked if Q3 had upwards close to or above 500k in revenue. That's just the extrapolating I did based on order numbers we have seen and stock availability. I'm also trying to be conservative. I could most certainly be wrong but even so Tweed's margins right now are much much better.

My week day handle is "EngageFactor".